Board Meeting10 Aug 2026, 07:21 pm
Gufic Biosciences Board Meeting on Aug 14 to Approve Unaudited Results
AI Summary
Gufic Biosciences Ltd has announced that its Board of Directors will convene on August 14, 2026. The primary agenda item is the consideration and approval of the company's Unaudited Financial Results for the quarter ended June 30, 2026. These results will be presented on both a standalone and consolidated basis. Additionally, the company confirmed that the trading window for its equity shares will remain closed until 48 hours after the declaration of these financial results, in line with SEBI regulations and the company's insider trading code.
Key Highlights
- Board meeting scheduled for August 14, 2026.
- To consider and approve Unaudited Financial Results.
- Results will be for the quarter ended June 30, 2026.
- Standalone and consolidated results to be presented.
- Trading window closure extended post-results declaration.
Price Impact
More from GUFICBIO